Your browser doesn't support javascript.
loading
Author Correction: Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cell.
Gao, Yulong; Souza-Fonseca-Guimaraes, Fernando; Bald, Tobias; Ng, Susanna S; Young, Arabella; Ngiow, Shin Foong; Rautela, Jai; Straube, Jasmin; Waddell, Nic; Blake, Stephen J; Yan, Juming; Bartholin, Laurent; Lee, Jason S; Vivier, Eric; Takeda, Kazuyoshi; Messaoudene, Meriem; Zitvogel, Laurence; Teng, Michele W L; Belz, Gabrielle T; Engwerda, Christian R; Huntington, Nicholas D; Nakamura, Kyohei; Hölzel, Michael; Smyth, Mark J.
Afiliação
  • Gao Y; Immunology in Cancer and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Souza-Fonseca-Guimaraes F; School of Medicine, The University of Queensland, Herston, Queensland, Australia.
  • Bald T; Immunology in Cancer and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Ng SS; Molecular Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Department of Medical Biology and The University of Melbourne, Parkville, Victoria, Australia.
  • Young A; Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, Victoria, Australia.
  • Ngiow SF; Immunology in Cancer and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Rautela J; Immunology and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Straube J; School of Natural Sciences, Griffith University, Nathan, Queensland, Australia.
  • Waddell N; Immunology in Cancer and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Blake SJ; School of Medicine, The University of Queensland, Herston, Queensland, Australia.
  • Yan J; Immunology in Cancer and Infection, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Bartholin L; Molecular Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Department of Medical Biology and The University of Melbourne, Parkville, Victoria, Australia.
  • Lee JS; Medical Genomics, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Vivier E; Medical Genomics, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Takeda K; Cancer Immunoregulation and Immunotherapy, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Messaoudene M; School of Medicine, The University of Queensland, Herston, Queensland, Australia.
  • Zitvogel L; Cancer Immunoregulation and Immunotherapy, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Teng MWL; Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de recherche en cancérologie de Lyon, Lyon, France.
  • Belz GT; Control of Gene Expression Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Engwerda CR; Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université, INSERM, CNRS, Marseille, France.
  • Huntington ND; Division of Cell Biology, Biomedical Research Center and Department of Biofunctional Microbiota, Graduate School of Medicine, Juntendo University, Bunkyo-ku, Tokyo, Japan.
  • Nakamura K; INSERM U1015, Gustave Roussy Cancer Campus, Villejuif, France.
  • Hölzel M; Gustave Roussy Cancer Campus, Villejuif, France.
  • Smyth MJ; Gustave Roussy Cancer Campus, Villejuif, France.
Nat Immunol ; 25(5): 925-926, 2024 May.
Article em En | MEDLINE | ID: mdl-38514890

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Nat Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Nat Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Austrália